4,544 results match your criteria: "Careggi University Hospital.[Affiliation]"
J Cardiovasc Med (Hagerstown)
January 2025
Cardiovascular Department, 'Azienda Sanitaria Universitaria Giuliano-Isontina', and University of Trieste, Trieste.
The knowledge of pericardial diseases has now improved, including prospective and retrospective cohort studies focusing on the pathogenesis, diagnosis, treatment, and outcomes. The complex interplay between genetic predisposition (especially for autoinflammatory conditions), inflammation, and autoimmunity is now known to trigger recurrences of pericarditis. Moreover, diagnostic capabilities have improved with the implementation of multimodality imaging, particularly cardiac magnetic resonance (CMR), to detect and monitor pericardial inflammation, to allow diagnosis in more complicated cases, and tailor the duration of therapy based on objective parameters.
View Article and Find Full Text PDFInfez Med
December 2024
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Introduction: Scabies is a neglected disease that cause outbreaks in facilities such as hospitals and prisons. In Europe, treatment with 2 doses of ivermectin 200 mcg/kg, 7 days apart, is authorised and recommended especially in population mass treatment. We describe the management of a mass pre-emptive therapy of primary contacts of a confirmed case of classic scabies among health care workers.
View Article and Find Full Text PDFMultimed Man Cardiothorac Surg
December 2024
Cardiac Surgery Unit, AOU Careggi University Hospital, Florence, Italy.
Type A aortic dissection is a life-threatening condition that requires immediate surgical intervention. The goal of traditional approaches is to treat the disease promptly, regardless of invasiveness, in order to achieve the quickest surgical outcome. This strategy has been shown to be associated with significant morbidity, extended recovery and postoperative complications.
View Article and Find Full Text PDFCephalalgia
December 2024
Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
Background: The present study aimed to determine whether machine-learning (ML)-based models can predict 3-, 6, and 12-month responses to the monoclonal antibodies (mAbs) against the calcitonin gene-related peptide (CGRP) or its receptor (anti-CGRPmAbs) in patients with migraine using early predictors (up to one month) and to create an evolving prediction tool.
Methods: In this prospective cohort study data from patients with migraine who had received anti-CGRP mAbs for 12 months were collected. Demographic and monthly clinical variables were collected, including monthly headache days (MHDs), days with acute medication use, number of analgesics and Headache Impact Test-6.
Stroke
February 2025
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy (M.F., E.D.M., F.D.S., F. Pistoia, R.O., S.S.).
Background: Sex may impact clinical outcomes in patients with stroke treated with dual antiplatelet therapy (DAPT). We aimed to investigate the sex differences in the short-term outcomes of DAPT within a real-world population of patients with noncardioembolic mild-to-moderate ischemic stroke or high-risk transient ischemic attack.
Methods: We performed a propensity score-matched analysis from a prospective multicentric cohort study (READAPT [Real-Life Study on Short-Term Dual Antiplatelet Treatment in Patients With Ischemic Stroke or Transient Ischemic Attack]) by including patients with noncardioembolic mild-to-moderate stroke (National Institutes of Health Stroke Scale score of 0-10) or high-risk transient ischemic attack (age, blood pressure, clinical features, duration of transient ischemic attack, presence of diabetes [ABCD] ≥4) who initiated DAPT within 48 hours of symptom onset.
Surg Laparosc Endosc Percutan Tech
December 2024
Azienda Ospedaliera S. Maria, Terni.
Background: Laparoscopic cholecystectomy is the gold standard in the treatment of symptomatic gallstones. The large number of gallbladders removed every year is not fully consistent with the excessively high incidence of iatrogenic bile duct injury (IBDI). Several strategies have been suggested to reduce this risk.
View Article and Find Full Text PDFInfection
December 2024
Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
Purpose: To describe the clinical characteristics and outcomes of patients with nosocomial pneumonia (NP) caused by carbapenem-resistant Gram-negative bacilli (CR-GNB) and to compare them to patients with NP caused by carbapenem-susceptible (CS)-GNB.
Methods: Prospective observational multicenter study including patients with bacteremic NP caused by GNB from the ALARICO Network (June 2018-January 2020). The primary outcome measure was 30-day mortality.
F S Sci
December 2024
Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Objective: To determine whether the bioactive sphingolipid sphingosine 1-phosphate (S1P) modulates cellular proliferation and synthesis of fibrotic proteins in leiomyoma differently than myometrial cells.
Design: A basic science study using human leiomyoma and myometrial cells.
Patient(s): Not applicable.
Mult Scler Relat Disord
December 2024
Department of Clinical Medicine, University of Bergen, Bergen, Norway; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway. Electronic address:
Background: Alemtuzumab is approved in the European Union for treating highly active relapsing-remitting multiple sclerosis (RRMS). Patient-reported outcomes measure the treatment impact on quality of life (QoL), including fatigue, a common symptom in multiple sclerosis (MS). Chronic diseases like MS also affect the patient's caregiver.
View Article and Find Full Text PDFPLoS One
December 2024
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Eur Radiol
December 2024
Department of Neurological and Vision Sciences, Neurology Unit, ASST Spedali Civili, Brescia, Italy.
Minerva Anestesiol
December 2024
Department of Health Science Anesthesia and ICU, School of Medicine, San Carlo Hospital, University of Basilicata, Potenza, Italy.
Nutr Metab (Lond)
December 2024
Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
JACC Case Rep
November 2024
Interventional Cardiology, Careggi University Hospital, Florence, Italy.
EuroIntervention
December 2024
St. Francis Hospital, Roslyn, NY, USA.
Early Hum Dev
January 2025
Department of Neuroscience, Psychology, Drug Research and Child Health, Careggi University Hospital of Florence, Largo Brambilla 3, 50134 Firenze, Italy.
Arch Womens Ment Health
November 2024
Psychiatry Unit, Department of Health Sciences, University of Florence, Largo Brambilla 3, 50100, Florence, Italy.
Heart Rhythm
November 2024
Barts Heart Centre, Barts Health NHS Trust, London, UK; Center for Inherited Cardiovascular Diseases, WellSpan Health, Lancaster, Pennsylvania, USA; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA; Center for Inherited Cardiovascular Disease, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Electronic address:
Andrology
November 2024
Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
Ther Adv Musculoskelet Dis
November 2024
Department of Medicine, Surgery and Neurosciences, Rheumatology Unit of Azienda Ospedaliero-Universitaria Senese, University of Siena, Siena, Italy.
JAMA Neurol
January 2025
Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Sci Rep
November 2024
Department of Health Science, University of Florence, Florence, 50134, Italy.
Haematologica
November 2024
Medical Faculty, Masaryk University, Brno, Czech Republic.
Haematologica
November 2024
Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende.
J Anal Toxicol
November 2024
FT-LAB, Department of Health Science, University of Florence.